Should You Hold Semler Scientific (SMLR)?

Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy returned 7.19% net of fees in the fourth quarter compared to 7.56% for the S&P 500 and 7.09% for the Russell 3000. The strategy returned 23.21% (net) since inception on January 11, 2022, compared to 40% for the S&P 500 index. In addition, please check the fund’s top five holdings to know its best picks in 2022.

Kingdom Capital Advisors highlighted stocks like Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter 2022 investor letter. Headquartered in Santa Clara, California, Semler Scientific, Inc. (NASDAQ:SMLR) is a technology solution-providing company to improve the clinical effectiveness and efficiency of the healthcare industry. On April 6, 2023, Semler Scientific, Inc. (NASDAQ:SMLR) stock closed at $23.07 per share. One-month return of Semler Scientific, Inc. (NASDAQ:SMLR) was 4.86%, and its shares lost 51.72% of their value over the last 52 weeks. Semler Scientific, Inc. (NASDAQ:SMLR) has a market capitalization of $157.903 million.

Kingdom Capital Advisors made the following comment about Semler Scientific, Inc. (NASDAQ:SMLR) in its Q4 2022 investor letter:

“Semler Scientific, Inc. (NASDAQ:SMLR) is a good business that declined rapidly in late 2021 and early 2022 as multiples compressed, offering a valuation we felt was compelling. Unfortunately, changes in the business during 2022, and Management’s shifting narrative, resulted in a steeply declining share price. We continue to watch the situation carefully for signs that the issues are addressed.”

Source: Unsplash

Semler Scientific, Inc. (NASDAQ:SMLR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 8 hedge fund portfolios held Semler Scientific, Inc. (NASDAQ:SMLR) at the end of the fourth quarter which was 12 in the previous quarter. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.